TAK-583

DRUG2 trials

Sponsors

Takeda

Conditions

Diabetic NeuropathiesNeuralgia, Postherpetic

Phase 2

Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia

CompletedNCT00377598

TakedaNeuralgia, Postherpetic

Start: 2006-10-31End: 2008-02-29Updated: 2012-02-02

Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy

CompletedNCT00760955

TakedaDiabetic Neuropathies

Start: 2006-09-30End: 2008-02-29Updated: 2016-06-22